Huapont-Nutrichem Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Huapont-Nutrichem Co Ltd with three other
companies in this sector in China:
Livzon Pharmaceutical Group Incorporated
sales of 7.65 billion Chinese Renmimbi [US$1.18 billion]
of which 42%
was Western Medicine),
Dong-E-E-Jiao Co Ltd
(6.32 billion Chinese Renmimbi [US$977.70 million]
of which 89%
was Medicine Manufacturing), and
Chongqing Taiji Industry (Group)
(7.78 billion Chinese Renmimbi [US$1.20 billion]
of which 52%
During the year ended December of 2016, sales at
Huapont-Nutrichem Co Ltd were 7.09 billion Chinese Renmimbi (US$1.10 billion).
increase of 15.0%
versus 2015, when the company's sales were 6.17 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Huapont-Nutrichem Co Ltd
(and since 2011, sales have increased a total of 1,011%).
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
694.4% in 2016, from
9.69 million Chinese Renmimbi to 76.97 million Chinese Renmimbi.
Huapont-Nutrichem Co Ltd also saw significant increases in sales in
Headquarters (up 198.4% to 4.04 million Chinese Renmimbi)
Not all segments of Huapont-Nutrichem Co Ltd experienced an increase in sales in 2016:
sales of Chemical Materials fell 16.8% to 226.54 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Huapont-Nutrichem Co Ltd also experienced decreases in sales in
Tourism (down 1.1% to 54.63 million Chinese Renmimbi)